Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FD8JP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,958
Award facts
- Contract value 100% obligated
- $10,958.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,958.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose-2 pen/mL pharmaceutical products. The award, issued on June 5, 2025, with an ultimate completion date of June 6, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
The delivery order supports the DLA Medical Supply Chain's mission to furnish pharmaceutical products across multiple therapeutic domains to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name drugs, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitive awards for firm fixed-price delivery orders, ranging from nominal amounts to substantial orders, underscores its established position as a qualified federal pharmaceutical vendor and its ability to fulfill diverse military medical supply requirements efficiently.
Quick answers
Who was awarded contract SPE2DB25FD8JP?
SPE2DB25FD8JP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FD8JP worth?
The government has obligated $10,958 on SPE2DB25FD8JP.
Is contract SPE2DB25FD8JP an order under another contract?
Yes. SPE2DB25FD8JP is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD8JP competed?
The extent of competition for SPE2DB25FD8JP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award